ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cost Effectiveness Analysis of Genetic Testing for Breast and Ovarian Cancer Susceptibility Genes:BRCA1andBRCA2
The Breast Journal
◽
10.1111/tbj.12269
◽
2014
◽
Vol 20
(3)
◽
pp. 325-326
◽
Cited By ~ 3
Author(s):
Rajesh Kaldate
◽
Alissa Huston
◽
Heidi McCoy
◽
Dawn Cardeiro
◽
Katia Noyes
Keyword(s):
Ovarian Cancer
◽
Genetic Testing
◽
Cost Effectiveness
◽
Cancer Susceptibility
◽
Cost Effectiveness Analysis
◽
Breast And Ovarian Cancer
◽
Effectiveness Analysis
Download Full-text
Related Documents
Cited By
References
Cost-Effectiveness Analysis of a Low-Fat Diet in the Prevention of Breast and Ovarian Cancer
Journal of the American Dietetic Association
◽
10.1016/j.jada.2010.10.011
◽
2011
◽
Vol 111
(1)
◽
pp. 56-66
◽
Cited By ~ 8
Author(s):
Antônio M. Bós
◽
Barbara V. Howard
◽
Shirley A.A. Beresford
◽
Nicole Urban
◽
Lesley F. Tinker
◽
...
Keyword(s):
Ovarian Cancer
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Low Fat
◽
Breast And Ovarian Cancer
◽
Low Fat Diet
◽
Effectiveness Analysis
Download Full-text
Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial
Gynecologic Oncology
◽
10.1016/j.ygyno.2016.04.116
◽
2016
◽
Vol 141
◽
pp. 36
Author(s):
W.Z. Wysham
◽
E.M. Schaffer
◽
T.M. Coles
◽
D.R. Roque
◽
S.B. Wheeler
◽
...
Keyword(s):
Ovarian Cancer
◽
Cost Effectiveness
◽
Single Agent
◽
Recurrent Ovarian Cancer
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Platinum Resistant
◽
Single Agent Chemotherapy
Download Full-text
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation
Nicotine & Tobacco Research
◽
10.1080/14622200701767761
◽
2008
◽
Vol 10
(1)
◽
pp. 231-240
◽
Cited By ~ 27
Author(s):
Nicky Welton
◽
Elaine Johnstone
◽
Sean David
◽
Marcus Munafò
Keyword(s):
Smoking Cessation
◽
Genetic Testing
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Treatment Choice
◽
Effectiveness Analysis
Download Full-text
Genetic Testing for Breast and Ovarian Cancer Susceptibility
Oncology Times
◽
10.1097/01.cot.0000314439.49855.10
◽
2004
◽
Vol 26
(21)
◽
pp. 68
Author(s):
&NA;
Keyword(s):
Ovarian Cancer
◽
Genetic Testing
◽
Cancer Susceptibility
◽
Breast And Ovarian Cancer
Download Full-text
Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors
JAMA Network Open
◽
10.1001/jamanetworkopen.2020.13565
◽
2020
◽
Vol 3
(9)
◽
pp. e2013565
Author(s):
Sudeep Banerjee
◽
Abhishek Kumar
◽
Nicole Lopez
◽
Beiqun Zhao
◽
Chih-Min Tang
◽
...
Keyword(s):
Genetic Testing
◽
Cost Effectiveness
◽
Gastrointestinal Stromal Tumors
◽
Cost Effectiveness Analysis
◽
First Line
◽
Stromal Tumors
◽
First Line Therapy
◽
Effectiveness Analysis
◽
Line Therapy
Download Full-text
A cost-effectiveness analysis of universal genetic testing for common hereditary cancer mutations in women compared with family-history based testing
Gynecologic Oncology
◽
10.1016/j.ygyno.2019.03.152
◽
2019
◽
Vol 153
(3)
◽
pp. e20
Author(s):
A.B. Drummey
◽
J. Brown
◽
L. Drury
◽
L. Amacker-North
◽
K. Warsinske
◽
...
Keyword(s):
Genetic Testing
◽
Cost Effectiveness
◽
Family History
◽
Hereditary Cancer
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Cancer Mutations
Download Full-text
PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis
Gynecologic Oncology
◽
10.1016/j.ygyno.2015.08.013
◽
2015
◽
Vol 139
(1)
◽
pp. 59-62
◽
Cited By ~ 25
Author(s):
Haller J. Smith
◽
Christen L. Walters Haygood
◽
Rebecca C. Arend
◽
Charles A. Leath
◽
J. Michael Straughn
Keyword(s):
Ovarian Cancer
◽
Cost Effectiveness
◽
Maintenance Therapy
◽
Parp Inhibitor
◽
Recurrent Ovarian Cancer
◽
Cost Effectiveness Analysis
◽
Platinum Sensitive
◽
Effectiveness Analysis
Download Full-text
PCN14: CHEMOTHERAPY-INDUCED NEUROPATHY IN OVARIAN CANCER COST EFFECTIVENESS ANALYSIS
Value in Health
◽
10.1016/s1098-3015(11)71574-1
◽
2001
◽
Vol 4
(6)
◽
pp. 436
Author(s):
JW Hay
◽
BV Patel
Keyword(s):
Ovarian Cancer
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Cancer Cost
Download Full-text
OP2. Cost-effectiveness analysis of paclitaxel and cisplatinum versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer — A European perspective
European Journal of Cancer
◽
10.1016/s0959-8049(97)85881-9
◽
1997
◽
Vol 33
◽
pp. S1
Author(s):
K Berger
◽
T Szucs
Keyword(s):
Ovarian Cancer
◽
Cost Effectiveness
◽
Advanced Ovarian Cancer
◽
Cost Effectiveness Analysis
◽
European Perspective
◽
First Line
◽
First Line Therapy
◽
Effectiveness Analysis
◽
Line Therapy
Download Full-text
A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events
The Pharmacogenomics Journal
◽
10.1038/tpj.2017.33
◽
2017
◽
Vol 18
(3)
◽
pp. 391-397
◽
Cited By ~ 5
Author(s):
M E Moretti
◽
D F Lato
◽
H Berger
◽
G Koren
◽
S Ito
◽
...
Keyword(s):
Genetic Testing
◽
Cost Effectiveness
◽
Adverse Events
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Postpartum Pain
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close